New combo therapy aims to hold liver cancer at bay for transplant patients
NCT ID NCT01918683
Summary
This study is testing whether combining two procedures helps control liver cancer in patients waiting for a liver transplant. It compares a standard procedure (TACE) to that same procedure plus targeted radiation (SBRT). The goal is to see if the combination is more effective at keeping the cancer from growing while patients are on the transplant waiting list.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Loyola University Medical Center
Maywood, Illinois, 60153, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
Conditions
Explore the condition pages connected to this study.